A close look at monoclonal antibodies for managing canine OA painJanuary 15, 2026As veterinary care continues to shift toward preventive medicine and lifelong wellness, there is growing momentum around improving earlier detection and more consistent pain management. Among the emerging therapeutic options is a new class of biologics: monoclonal antibodies (mAbs).
SPONSORED CONTENTHill's Prescription Diet Metabolic Weight + j/dNutrition to help mobility in as little as 1 month. 88% of pets lost weight in 2 months at home with Metabolic nutrition. + Learn More
Monoclonal antibody (mAb) product innovation aim of facility expansion in KansasAugust 23, 2024A $130-million investment through 2026 is expected to bolster production and development of monoclonal antibody-based therapy, including a potential product in canine dermatology.
